Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OROS Hydromorphone in Osteoarthritis
NCT00411164Phase 3Completed
- Sponsor
- ALZA Corporation
- Start
- Nov 2003
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of hydromorphone in osteoarthritis (OA), sponsored by ALZA Corporation. Started Nov 2003; status: completed.
02
Drugs
hydromorphone
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00411164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00411164.